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Arachidonic acid [20: 4(n-6(] and other 20-carbon polyunsaturated fatty acids (PUFA) are metabolized by mammalian oxygenases to a group of biologically active products collectively referred to as the eicosanoids. These autacoids play a major role in the regulation of several pathophysiological processes, notably inflam mation and thrombosis. The involvement of eicosa noids in the pathogenesis of diseases had led to an increasing desire to modulate eicosanoid synthesis. The principal means of altering eicosanoid levels had tradi tionally involved pharmacological intervention, which has often been accompanied by deleterious side effects. To minimize these effects, recent efforts have focused on the ability of dietary manipulation to alter tissue levels of eicosanoid precursor fatty acids and thereby directly to regulate the source of tissue eicosanoids.
An example of this manipulation is the use of dietary fish oil supplements in the management of psoriasis (1--3) ,an inflammatory skin disorder characterized by an infiltration of neutrophils into the epidermis (4) . Ex tracts from lesionai areas of psoriasis are known to contain elevated levels of the neutrophil arachidonic acid product leukotriene B4(LTB4) (5, 6) . This eicosanoid, a product of neutrophil 5-lipoxygenase, is a potent in flammatory mediator that can elicit psoriasis-like symptoms when applied to normal skin (7) (8) (9) . Although fish oil has low levels of the (n-6) fatty acid arachidonic acid, it is rich in the (n-3) fatty acids eicosapentaenoic acid [20:5(n-3|] and docosahexaenoic acid [22:6(n-3)] (10). A possible mechanism for the beneficial effects of fish oil on psoriasis was presumed to be related to findings that the incorporation of 20:5(n-3) into neutrophils re sults in a competitive inhibition of neutrophil conver sion of 20:4(n-6) into LTB4 (11, 12) . However, the clinical improvement in psoriatic patients fed fish oil reportedly does not correlate with the ability of peripheral neutro phils to synthesize LTB4 (2) , but it does correlate with elevated levels of 20:5(n-3) incorporated into the epider-mis (1) . This latter observation suggests that an addi tional effect of 20:5(n-3)or eicosanoids derived from this fish oil constituent may exert effects at the epidermal lesion.
Another example of the use of dietary oil is dietary supplementation with evening primrose oil, which is rich in y-linolenic acid [18:3(n-6J]and has been reported to alleviate the clinical signs of atopic eczema (13, 14) . Like psoriasis, this inflammatory skin disorder is asso ciated with elevated lesionai levels of LTB4 (15) . The supplementation of guinea pig diets with vegetable oils rich in y-linolenic acid [18:3(n-6)]resulted in increased epidermal levels of dihomo-y-linolenic acid [20:3(n-6)| (16, 17) ,the epidermal elongase product of 18:3(n-6) (18) . Epidermal extracts from these animals also showed increased levels of 15-lipoxygenase product derived from 20:3(n-6), 15-hydroxyeicosatrienoic acid (15-HETrE) (17) . In in vitro experiments, 15-HETrE was shown to be a potent inhibitor of LTB4synthesis much like 15-hydroxyeicosapentaenoic acid (15-HEPE) (19, 20) .
The successful use of dietary oils rich in 20:5(n-3) or 18:3(n-6) in treating inflammatory skin disorders sug gests that the incorporation of specific PUFA into epi dermal lipids followed by the conversion of these fatty acids into 15-lipoxygenase products may provide for the in vivo generation of anti-inflammatory mediators. Fur thermore, it has been proposed that different classes of phospholipids may act as donors of precursor fatty acids for eicosanoid synthesis (21-23); however, no such ef forts have been made to evaluate how dietary oils may influence the distribution of fatty acids in the individual epidermal phospholipids in vivo and how this would influence the levels of epidermal 15-lipoxygenase prod ucts that are generated. To answer these questions, guinea pigs were fed a basal diet supplemented with either 6% olive oil (control), 3% olive oil + 3% borage oil [containing approximately 25% 18:3(n-6)], or 3% olive oil + 3% fish oil [containing approximately 20% 20:5(n-3) and 17% 22:6(n-3)].The epidermis from these animals was analyzed for the distribution of incorpo rated (n-6) and (n-3) fatty acids in individual phospho lipids to determine whether the incorporation of specific PUFA into the epidermis resulted in the in vivo generation of significant levels of the corresponding 15-lipoxygenase products.
MATERIALS AND METHODS

Dietary treatment. Male weanling Hartley guinea
pigs (n = 27) (Simonsen, Gilroy, CA) were fed a basal purified control diet that contained 6% olive oil by weight. The animals were housed individually in a cage at 22-24Â°Cwith a 12-h diurnal light cycle; deionized water (containing 0.05% ascorbic acid) and diet were provided ad libitum. After the animals had acclimated Table 1 and the fatty acid composition of the dietary oils is shown in Table 2 . The diets were initially mixed in a powder form and stored under N2 at -20Â°C. A purified diet in gel form was prepared with agar as described previously (22) .The gel-type diets were flushed with N2 and stored at 4Â°C. Diets were periodically analyzed for autoxidation by checking fatty acid profiles. Fresh diet was provided daily to each group to minimize autoxida tion. Body weights were recorded three times per week throughout the study. There were no significant differ ences in the growth curves of the three groups ( Fig. 1 ) and no macroscopic differences in the appearance of the animals were discernible. Because there were no symp-
TABLE2
Fatty acid composition of dietary oils1
Fatty acid16:0216:l|n-7)18:018:l(n-9)18:2(n-6)18:3|n-6)20:4|n-6)20:5|n-3)22:6(n-3)OLI12.550.030.0569.89 (11. 78]3â€"â€"â€"â€"BORwÃ- 'Values are expressed as mg/100 mg total fatty acids. OLI, 100% olive oil; BOR, 50% olive oil + 50% borage oil; FBO, 50% olive oil + 50% fish body oil.
2Only the major fatty acids are listed. Brackets represent polyunsaturated fatty acids.
toms of essential fatty acid deficiency, the energy per centage of 18:2(n-6) in the three diets (OLI, 1.7%; BOR, 3.8%; and FBO, 1.0%) appeared to be adequate. At 4-wk intervals starting from the initiation of feeding the experimental diets (wk 4, 8 and 12), three animals from each group were killed for analyses of epidermal lipids and eicosanoids. Lipid analysis. To isolate the epidermis from the guinea pigs, the animals were shaved, their hair was removed by depilatory and they were killed. Epidermal slices from areas of the dorsum (0.2 mm thick) were quickly removed by a motor-driven keratome (Storz, St. Louis, MO) over ice as previously described (16) . The epidermal strips were rapidly placed in ice-cold 0.1 M KC1 and homogenized over ice using a Polytron (Brinkmann Instruments, Westbury, NY). A portion of the crude epidermal homogenate was used to quantitate protein concentration by a modified Lowry method (24) .
Isolation and separation of individual phospholipids. Lipids from a portion of the crude epidermal homogenate were extracted with CHCl3:MeOH (2:1, v.v) as described previously (25) . To isolate individual phospholipids, the extracted total lipids were fraction ated by thin layer chromatography on 0.25-mm silica gel G plates (Merck, Darmstadt, West Germany) using CHCl3:methanol acetic acid:H2O (50:37.5:3.5:2, v/v/v/v) (26) . The individual phospholipids were visual ized under ultraviolet light after spraying with 0.2% 2',7'-dichlorofluorescein in ethanol. The phospholipid fractions were scraped off the plates, eluted from the silica gel and then dried under N2 gas; diheptadecanoyl-L-a-phosphatidylcholine was added as an internal stan dard to determine the relative contribution of fatty acids from each phospholipid class. After transmethylation of the individual phospholipids in 6% methanolic-HCl at DAY FIGURE 1 Average weight of guinea pigs fed diets supple mented with 6% olive oil (OLI) (n = 9), 3% olive oil + 3% fish body oil (FBO) (n = 9) or 3% olive oil + 3% borage oil (BOR). Each group included nine animals. The three growth curves did not significantly differ (P > 0.05).
70Â°C for 14 h as described previously (16) , the fatty acid profiles of these fractions were determined by gas chro matography. The gas Chromatograph (Hewlett-Packard model 5730A, Avon dale, PA) was equipped with a DB-225 fused silica capillary column (50% cyanopropylphenyl, 0.15-um film thickness, 30 m x 0.25 mm i.d.; J&W Scientific, Rancho Cordova, CA). Hydrogen (36 cm/s) was used as the carrier gas, the oven was run isothermically at 200Â°C, and detection was performed by flame ionization.
Isolation and identification of lipoxygenase prod ucts. The eicosanoids from the epidermal homogenates were extracted with ice-cold CHCl3:MeOH (2:1, v/v) after acidification to pH 3.0. The profiles of the hydroxy fatty acids of the epidermal extracts were determined by reverse phase high performance liquid chromatography (RP-HPLC) using a Beckman 5-um octadecylsilica (ODS) column (25 cm x 4.6 mm i.d., Beckman, Palo Alto, CA). The Chromatographie system was run isocratically at a flow rate of 1.0 mL/min on a Beckman system equipped with Model 100A/110A pumps and a 421 Controller. The mobile phase solvents were methanol (74% )and water acidified to pH 3.0 with acetic acid (27 Isolation and identification of the cyclooxygenase products. Prostaglandins were analyzed using RP-HPLC and a mobile phase of acetonitrile (ACN) and water containing 0.02% H3PO3 (17) .The system was run at a constant flow rate of 1.0 mL/min with a successive gradient of 34% ACN (0-15 min) and 65% ACN (15-30 min). The prostaglandins were monitored at 205 nm and were quantitated against external standards for prosta glandins PGFiÂ«, PGE2,PGD2 and PGE! (Cayman Chem icals).
Statistical analysis. Data were assessed by one-way analysis of variance (ANOVA) comparing the means of the dietary groups within 4-wk periods. Significant dif ferences were determined by the Student-NewmanKeul's (SNK) range test (28) . The upper level of significance was chosen as P < 0.05.
RESULTS
Fatty acids in individuai epidermal phospholipids.
Analysis of the individual epidermal glycerophospholipids (PL)revealed that phosphatidylcholine (PC),phos phatidylethanolamine (PE) and combined phosphatidylserine/phosphatidylinositol (PS/PI) repre sented 52.6%, 29.1% and 18.2% of total glycerophos pholipids, respectively (Fig.3 ).There were no significant differences in the epidermal phospholipid compositions of the three dietary groups at any time point.
The effect of diet on individual phospholipid fatty acids is presented in Table 3 . Only data for the PUFA, the fatty acids that are probable substrates for enzymatic oxygÃ©nation, are listed. Statistical analysis was per formed for values within a PL class for each time point (wk 4, 8 or 12).These results clearly indicate the signif icant effects of the dietary oils on the fatty acid compo sition of the epidermal phospholipids. The observed differences generally reflected the differences in the fatty acid compositions of the diets ( Table 2 In fact an analysis ofof epidermal 15-lipoxy-genÃ¤se products and the levels of epidermal phos-DholÃOEDÃOEdfattvacidsvieldedr and r = 0.413 for PE (P < 0.0125).
In addition to the 15-lipoxygenase products, an anal ysis of the epidermal extracts also indicated the pres ence of 12-HETE, the 12-lipoxygenase product of 20:4(n-6). The levels of 12-HETE were not significantly different at wk 4 and 8; the only significant differences in 12-HETE levels occurred at wk 12 in the animals fed FBO.There were no detectable levels of 12-lipoxygenase products from 20:5(n-3) (12-HEPE) or 20:3(n-6) (12-HETrE) in the epidermis of any of the animals.
Epidermal cyclooxygenase products. Analysis of the epidermal levels of prostaglandins at wk 4, 8 and 12 did not show any significant differences between the dietary groups; mean levels of PGE2were at 2600 ng/mg protein, followed by PGF2aand PGD2 at 2100 ng/mg protein and 1600 ng/mg protein, respectively. Prostaglandin EI, a cyclooxygenase metabolite of 20:3(n-6), was present in the epidermis of the animals fed BOR, although the amounts present were relatively small (-200 pg/mg protein) and variable.
DISCUSSION
Although the ability of dietary oils to alter the fatty acids present in cellular phospholipids has been estab lished in several tissues, the exploration of this manip ulation in the epidermis has not been well examined. Furthermore, the effects of these diet-induced changes in fatty acid content on epidermal levels of eicosanoids, the products of lipoxygenase and cyclooxygenase en zymes, were even less clear. The present study indicates that the feeding of diets rich in eicosapentaenoic acid [20:5(n-3(] or y-linolenic acid [18:3(n-6)jcan profoundly affect epidermal phospholipid fatty acid composition and the local tissue content of eicosanoids. These find ings suggest that it may be possible, via dietary manip ulation, to alleviate cutaneous disorders associated with fatty acid or eicosanoid imbalance.
Specifically, our data show that feeding guinea pigs a diet supplemented with fish oil (FBO),which is rich in (n-3) fatty acids, or a diet supplemented with borage oil (BOR),which is rich in 18:3(n-6),resulted in significant incorporation of (n-3) fatty acids [20:5(n-3|]and [22:6(n-3)] or an 18:3(n-6)-derived fatty acid [20:3(n-6|] into epidermal phospholipids, respectively. These findings agree with earlier reports in which dietary oils were shown to exert a profound effect on the fatty acid com position of epidermal total phospholipids (16, 17) . The current study extends these previous studies by demon strating the relationship between dietary intake of fish oils rich in (n-3) or vegetable oils rich in 18:3(n-6)on the incorporation of specific fatty acids into individual phospholipid classes.
The data presented in Table 3 demonstrate that the constituent fatty acids of dietary oils are readily incor porated into individual epidermal phospholipids, as ev idenced by the analysis of fatty acid profiles in epider mal PC, PE and PS/PI phospholipid fractions. In the animals fed FBO,dietary 20:5(n-3)was incorporated into epidermal PC, PE and PS/PI; 22:6(n-3)was incorporated preferentially into epidermal PE, with lesser quantities incorporated into PS/PI and none detected in PC. This agrees with studies of fatty acid uptake in human plate lets that have shown that labeled 22:6(n-3) is preferen tially incorporated into PE compared with labeled 20:5(n-3), which is preferentially incorporated into PC (26) . In the animals fed BOR, dietary 18:3(n-6) results first in the in vivo elongation of 18:3(n-6) to 20:3(n-6) followed by increased incorporation of 20:3(n-6) into epidermal PE, PS/PI and, particularly, PC. This agrees with similar studies with mice fed an 18:3(n-6)enriched diet that resulted in elevated absolute 20:3(n-6) in all macrophage phospholipid classes, with PC representing the largest gains (29) .
The importance of the fatty acid composition of epidermal phospholipids is evidenced by the relation ship between epidermal phospholipid fatty acids and the epidermal levels of 15-lipoxygenase products. Insignifi cant changes in 13-HODEand 15-HETE,the most abun dant epidermal lipoxygenase products, reflect the insignificant changes in the levels of the precursor fatty acids 18:2(n-6)and 20:4(n-6). However, coinciding with the changes in the fatty acid profiles of the epidermal phospholipids described above, the epidermis of the animals fed the FBOdiet had elevated levels of 15-HEPE [the 15-lipoxygenase product of 20:5(n-3)],whereas the epidermis of animals fed the BOR diet had elevated levels of 15-HETrE (the 15-lipoxygenase product of 20:3(n-6) ( Table 4) . Notably absent in the epidermis of animals fed the FBOdiet was any detectable amount of 17-HDHE, the 15-lipoxygenase product of 22:6(n-3). These data suggest that PE, into which 22:6(n-3) was preferentially incorporated, may resist hydrolysis by phospholipase A2,thus making 22:6(n-3)unavailable for lipoxygenation into 17-HDHE.
The possibility that the epidermal 15-lipoxygenase utilizes specific fatty acid pools (i.e., PC) remains to be confirmed. However, a comparison of the ratios of the levels of epidermal hydroxy fatty acids to the levels of precursor fatty acids in epidermal PC and PE (Fig. 4) suggests a specific relationship between the fatty acids in PC and their utilization by the epidermal 15-lipoxy genase. Analysis of correlation further implies that the levels of epidermal hydroxy fatty acids are related to the levels of fatty acids in epidermal PC (r = 0.958; P < 0.00005) but not to those in epidermal PE (r = 0.413; P < 0.0125). Although the exact relationship between epidermal PC and the epidermal 15-lipoxygenase re mains to be fully elucidated, it has been demonstrated that PC is probably the major source of substrate fatty acid for human platelet 12-lipoxygenase (23) and for porcine aortic endothelial 5-and 15-lipoxygenases (21) . It has also been reported that PC itself can be directly oxygenated at carbon-15 of the PUFA moiety by 15-lipoxygenases in rabbit reticulocytes (30) and human polymorphonuclear leukocytes (31) .
The importance of the generation of 15-lipoxygenase products in the epidermis in vivo relates to findings that the 15-lipoxygenase products inhibit the formation of pro-inflammatory 5-lipoxygenase products in vitro. Our results indicate that the feeding of diets rich in 20:5(n-3) or 18:3(n-6) can lead to increased levels of the 15-lipoxy genase products 15-HEPE and 15-HETrE, respectively. Both 15-HEPE (32) and are more potent inhibitors of 5-lipoxygenase in vitro than either 15-HETE or 13-HODE; thus, the increases in the levels of 15-HEPE and 15-HETrE observed in the epidermis of the guinea pigs that were fed diets enriched with 20:5(n-3) or 18:3(n-6) may lead to a substantial tissue increase of endogenous epidermal 5-lipoxygenase inhibitors. Such an elevation could conceivably suppress the in vivo activity of 5-lipoxygenase. Because chronic inflamma tory skin disorders such as psoriasis and atopic eczema are associated with increased levels of the 5-lipoxy genase product LTB4 (5, 6, 15) , the possibility that diets rich in 20:5(n-3) or 18:3(n-6) could enhance epidermal levels of potential 5-lipoxygenase inhibitors in vivo may explain partially how fish oil, rich in 20:5(n-3), was reported to improve the inflammatory aspects of psori asis (1-3 )and how evening primrose oil, rich in 18:3(n-6), was reported to be beneficial in the treatment of atopic eczema (13, 14) . Dietary supplementation with oils rich in specific PUFA may be an alternative therapy or may serve as an adjunct to conventional therapies used in the treatment of inflammatory disorders.
